Checkpoint Surgical today said it received FDA breakthrough device designation for its brief electrostimulation therapy system. The Cleveland-based company’s brief electrostimulation therapy (BEST) system is designed to stimulate peripheral nerves to promote nerve regeneration when used with surgical intervention following a nerve injury, according to the company. “We are pleased to receive the Breakthrough Device […]
Checkpoint Surgical
Checkpoint Surgical touts nerve monitor study results
Checkpoint Surgical today announced the results of a study that called its handheld nerve monitor a safe and reliable alternative to existing technology for neural monitoring during surgery. The retrospective study compared the use of the Cleveland, Ohio-based company’s Checkpoint nerve stimulator/locator to Medtronic’s nerve integrity monitor for vagal, recurrent and superior laryngeal nerve monitoring […]
Checkpoint Surgical raises $9m for neurostim device
Checkpoint Surgical said today that it raised another $9 million for the handheld nerve monitor it’s developing. The Cleveland-based company said the $8.8 million round was led by Mutual Capital Partners and included prior backers First Analysis, the JumpStart NEXT Fund and several individual investors. Checkpoint said it plans to use the proceeds to build out its sales […]
Checkpoint Surgical closes $7.5m funding round
Neuroprotective device maker Checkpoint Surgical said it closed its 1st round of institutional financing, bringing in $7.5 million for its Checkpoint handheld nerve monitor. The Checkpoint Stimulator/Locater stimulates motor nerves so surgeons can avoid damaging them during surgery. The device also helps physicians gauge nerve and muscle health. The device has been on the U.S. market since […]
Checkpoint Surgical raises $7.5M for nerve-detector technology
Checkpoint Surgical is looking for another $2.5 million to cap off a $10 million equity funding round originally launched in 2011, according to the company’s SEC documents.
Ortho market growth stable but low | Wall Street Beat
The market for hip and knee implants is stable but mired in a low-growth stage, according to analysts who attended the American Academy of Orthopedic Surgeons conference in San Francisco last week.
Although the abrupt departure of Stryker CEO Steve MacMillan drew the lion’s share of attention at the AAOS event, analysts from Barclays Capital and Leerink Swann agreed that the sector’s outlook calls for low-single-digit growth.
iRobot invests $6M into telemedicine company | Funding Roundup
iRobot Corp. (NSDQ: IRBT), famous for their Roomba automated cleaning robots, invested $6 million and launched an extended partnership with InTouch Health, which develops telemedicine systems for providing remote health care.
The venture builds on an existing relationship that the companies announced last summer, under which the companies engaged in a development and licensing agreement.
Northeast Ohio attracts neurotech cluster
Cleveland Clinic neuromodulation spinoff Intelect Medical may have stealthily exited Cleveland to set up shop in Boston, but the company’s recent $78 million sale to Boston Scientific (NYSE:BSX) highlights Northeast Ohio’s growing strength in neurotechnology.
Checkpoint Surgical launches nerves detector
By Mary Vanac
Checkpoint Surgical has begun a national launch of its hand-held device used to identify nerves during surgery.
The Checkpoint Stimulator/Locator stimulates motor nerves so surgeons can avoid damaging them during surgery. The device also helps physicians gauge nerve and muscle health.
Checkpoint Surgical pulls in $250,000 to build sales team
By Mary Vanac
Checkpoint Surgical Inc. raised an additional $250,000 from angel investor group Medical Growth Fund to build a sales force and distribution network for its disposable surgical device.
